Design of new reagents on the base of DNA duplexes for irreversible inhibition of transcription factor NF-κB

Antisense and Nucleic Acid Drug Development

Volumn 7, Issue 4, 1997, Pages 279-289

  Kozlov, Igor A ^a,b   Kubareva, Elena A ^a   Ivanovskaya, Marina G ^a   Shabarova, Zoe A ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; PYROPHOSPHATE;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; CROSS LINKING; DRUG DESIGN; DRUG SYNTHESIS; ESCHERICHIA COLI; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; X RAY CRYSTALLOGRAPHY;

EID: 0030763349     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1997.7.279     Document Type: Article

References (2)

1. AGRAWAL, S., TEMSAMANI, J., and TANG, J.Y. (1991). Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA 88, 7595-7599.
2. BAEUERLE, P.A. (1991). The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim. Biophys. Acta 1072, 63-80.